NCT03627299View on ClinicalTrials.gov

Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

December 19, 2019

Study Completion Date

September 20, 2021

Conditions
End Stage Renal DiseaseHepatitis C
Interventions
DRUG

300mg glecaprevir/pibrentasivir 120mg

300mg glecaprevir/pibrentasivir 120mg 4 weeks post-transplant

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03627299 - Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors | Biotech Hunter | Biotech Hunter